BlackRock’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Sell |
|
|||||
|
2025
Q1 | $37.1M | Sell |
|
|||||
|
2024
Q4 | $26.3M | Sell |
|
|||||
|
2024
Q3 | $38.9M | Buy |
|
|||||
|
2024
Q2 | $56.6M | Buy |
|
|||||
|
2024
Q1 | $91.7M | Buy |
|
|||||
|
2023
Q4 | $101M | Buy |
|
|||||
|
2023
Q3 | $86.8M | Sell |
|
|||||
|
2023
Q2 | $208M | Sell |
|
|||||
|
2023
Q1 | $207M | Buy |
|
|||||
|
2022
Q4 | $187M | Buy |
|
|||||
|
2022
Q3 | $189M | Buy |
|
|||||
|
2022
Q2 | $137M | Buy |
|
|||||
|
2022
Q1 | $91.2M | Sell |
|
|||||
|
2021
Q4 | $118M | Sell |
|
|||||
|
2021
Q3 | $127M | Buy |
|
|||||
|
2021
Q2 | $162M | Sell |
|
|||||
|
2021
Q1 | $248M | Buy |
|
|||||
|
2020
Q4 | $252M | Sell |
|
|||||
|
2020
Q3 | $183M | Sell |
|
|||||
|
2020
Q2 | $132M | Buy |
|
|||||
|
2020
Q1 | $78.9M | Sell |
|
|||||
|
2019
Q4 | $201M | Buy |
|
|||||
|
2019
Q3 | $389M | Buy |
|
|||||
|
2019
Q2 | $503M | Buy |
|
|||||
|
2019
Q1 | $425M | Buy |
|
|||||
|
2018
Q4 | $240M | Sell |
|
|||||
|
2018
Q3 | $398M | Buy |
|
|||||
|
2018
Q2 | $437M | Sell |
|
|||||
|
2018
Q1 | $608M | Buy |
|
|||||
|
2017
Q4 | $567M | Buy |
|
|||||
|
2017
Q3 | $184M | Sell |
|
|||||
|
2017
Q2 | $241M | Buy |
|
|||||
|
2017
Q1 | $203M | Buy |
|
|||||
|
2016
Q4 | $1.44M | Sell |
|
|||||
|
2016
Q3 | $1.86M | Buy |
|
|||||
|
2016
Q2 | $514K | Buy |
|
|||||
|
2016
Q1 | $29K | Buy |
|
|||||
|
2015
Q4 | $21K | Buy |
|
|||||
|
2015
Q3 | $13K | Hold |
|
|||||
|
2015
Q2 | $22K | Buy |
|
|||||
|
2015
Q1 | $7K | Sell |
|
|||||
|
2014
Q4 | $261K | Buy |
|
|||||
|
2014
Q3 | $217K | Buy |
|